Abstract

BackgroundThe use of drugs in children presents several problems of safety and tolerability, mainly due to lack of information about the risk-benefit profile in real conditions of use. Pharmacovigilance could...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
A nationwide survey of methods and barriers to adverse drug reaction monitoring and reporting among hospital pharmacists in Thailand.
Prangwalai Homket ... Narumol Jarernsiripornkul
The International journal of pharmacy practice | VOL. 31
Prangwalai Homket, et. al.Prangwalai Homket ... Narumol Jarernsiripornkul
15 Jul 2023
OHP-045 Incidence and risk factors of adverse drug reactions in the general population observed through an active pharmacovigilance project
M Vigano ... S Stabile
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
M Vigano, et. al.M Vigano ... S Stabile
24 Feb 2014
A study of the monitoring of the adverse drug reactions caused by antiretroviral drugs
...
International Journal of Pharmacological Research | VOL. 8
, et. al. ...
14 Feb 2018
“Black box” 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk
Rosemary Roberts ... Shirley Murphy
The Journal of Allergy and Clinical Immunology | VOL. 117
Rosemary Roberts, et. al.Rosemary Roberts ... Shirley Murphy
29 Dec 2005
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers